STERIS (STE) Financials

$210.84 -0.01 (0.00%)

Closing price 05/13/2026 03:59 PM Eastern

Extended Trading

$212.85 +2.01 (+0.95%)

As of 08:15 AM Eastern

Annual Income Statements for STERIS

This table shows STERIS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	110	291	304	408	397	244	107	378	615
Consolidated Net Income / (Loss)	111	292	305	408	397	243	106	380	616
Net Income / (Loss) Continuing Operations	111	292	305	408	397	284	556	553	612
Total Pre-Tax Income	185	355	369	499	518	367	680	703	796
Total Operating Income	226	400	411	537	548	478	791	836	867
Total Gross Profit	1,026	1,093	1,175	1,320	1,343	1,883	1,981	2,218	2,403
Total Revenue	2,613	2,620	2,782	3,031	3,108	4,223	4,536	5,139	5,460
Operating Revenue	2,613	2,620	2,782	3,031	3,108	4,223	4,536	5,139	5,460
Total Cost of Revenue	1,587	1,527	1,607	1,711	1,764	2,340	2,556	2,921	3,057
Operating Cost of Revenue	1,587	1,527	1,607	1,711	1,764	2,340	2,556	2,921	3,057
Total Operating Expenses	800	693	764	783	795	1,405	1,190	1,382	1,536
Selling, General & Admin Expense	682	632	670	717	731	1,318	1,091	1,252	1,334
Research & Development Expense	59	61	63	66	66	87	98	104	108
Other Operating Expenses / (Income)	-	-	-	-	-	-	0.00	-	48
Restructuring Charge	0.22	0.10	31	0.67	-2.91	0.05	0.49	26	46
Total Other Income / (Expense), net	-42	-45	-42	-38	-31	-111	-111	-133	-70
Interest Expense	45	51	45	40	37	89	108	144	86
Other Income / (Expense), net	2.96	5.73	3.02	1.99	6.35	-22	-2.88	11	16
Income Tax Expense	74	63	64	91	121	82	124	150	185
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-42	-450	-173	4.52
Net Income / (Loss) Attributable to Noncontrolling Interest	0.67	0.71	1.03	0.20	-0.53	-1.02	-1.22	1.84	1.43
Basic Earnings per Share	$1.29	$3.42	$3.59	$4.81	$4.66	$2.50	$1.07	$3.83	$6.24
Weighted Average Basic Shares Outstanding	-	-	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Diluted Earnings per Share	$1.28	$3.39	$3.55	$4.76	$4.63	$2.48	$1.07	$3.81	$6.20
Weighted Average Diluted Shares Outstanding	-	-	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Weighted Average Basic & Diluted Shares Outstanding	-	-	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Cash Dividends to Common per Share	$1.09	$1.21	$1.33	$1.45	$1.57	$1.69	$1.84	$2.03	$2.23

This table shows STERIS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	124	115	141	-1.38	145	150	174	146	177	192	193
Consolidated Net Income / (Loss)	124	116	141	-1.00	146	151	173	146	178	193	194
Net Income / (Loss) Continuing Operations	131	121	149	172	140	151	173	147	178	193	194
Total Pre-Tax Income	167	156	190	215	175	195	229	197	232	253	258
Total Operating Income	198	192	226	245	186	220	245	216	246	266	273
Total Gross Profit	529	546	560	449	572	579	610	641	628	646	656
Total Revenue	1,183	1,238	1,298	1,116	1,280	1,329	1,371	1,481	1,391	1,460	1,496
Operating Revenue	1,183	1,238	1,298	1,116	1,280	1,329	1,371	1,481	1,391	1,460	1,496
Total Cost of Revenue	654	692	738	668	707	750	760	839	763	814	841
Operating Cost of Revenue	654	692	738	668	707	750	760	839	763	814	841
Total Operating Expenses	331	355	334	203	387	359	365	425	382	380	382
Selling, General & Admin Expense	307	328	308	152	336	329	336	334	354	350	352
Research & Development Expense	25	26	25	25	26	27	27	28	26	28	30
Restructuring Charge	0.02	-0.02	0.01	26	26	2.80	2.20	15	1.80	2.20	0.40
Total Other Income / (Expense), net	-31	-36	-37	-30	-10	-25	-17	-19	-14	-13	-15
Interest Expense	32	37	39	36	30	20	19	17	16	15	15
Other Income / (Expense), net	1.38	1.24	2.08	6.33	20	-5.10	2.40	-1.73	1.80	2.20	-0.40
Income Tax Expense	36	35	41	43	35	44	55	50	54	61	64
Net Income / (Loss) Discontinued Operations	-6.79	-4.45	-7.66	-	5.60	-0.20	-0.10	-0.79	0.00	0.00	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	0.24	1.03	0.20	0.38	0.10	1.10	-0.20	0.40	0.60	0.60	1.50
Basic Earnings per Share	$1.25	$1.17	$1.42	($0.01)	$1.47	$1.52	$1.76	$1.49	$1.80	$1.95	$1.96
Weighted Average Basic Shares Outstanding	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M	98.15M	98.08M
Diluted Earnings per Share	$1.25	$1.16	$1.42	($0.02)	$1.46	$1.51	$1.75	$1.48	$1.79	$1.94	$1.96
Weighted Average Diluted Shares Outstanding	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M	98.15M	98.08M
Weighted Average Basic & Diluted Shares Outstanding	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M	98.15M	98.08M
Cash Dividends to Common per Share	$0.47	$0.52	$0.52	$0.52	$0.52	$0.57	$0.57	$0.57	$0.57	$0.63	$0.63

This table details how cash moves in and out of STERIS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Net Change in Cash & Equivalents	34	-81	19	99	-99	128	-140	-1.34	-35
Net Cash From Operating Activities	424	458	540	591	690	685	757	973	1,148
Net Cash From Continuing Operating Activities	424	458	540	591	690	685	757	973	1,142
Net Income / (Loss) Continuing Operations	111	292	305	408	397	243	106	380	616
Consolidated Net Income / (Loss)	111	292	305	408	397	243	106	380	616
Depreciation Expense	188	178	226	197	219	553	553	565	476
Amortization Expense	-	-	-	0.00	0.00	67	7.36	4.82	0.00
Non-Cash Adjustments To Reconcile Net Income	151	72	5.12	26	50	78	527	300	59
Changes in Operating Assets and Liabilities, net	-26	-84	3.72	-40	23	-256	-436	-277	-10
Net Cash From Investing Activities	-104	-204	-213	-320	-1,154	-667	-383	-887	389
Net Cash From Continuing Investing Activities	-104	-204	-213	-320	-1,154	-667	-383	-887	389
Purchase of Property, Plant & Equipment	-173	-165	-190	-215	-239	-288	-362	-360	-370
Acquisitions	-66	-46	-13	-110	-909	-550	-43	-546	-54
Purchase of Investments	-6.36	0.00	-4.96	0.00	-4.40	0.00	0.00	-1.50	-11
Sale of Property, Plant & Equipment	4.85	2.09	5.57	4.16	0.57	1.74	15	7.38	9.20
Divestitures	136	8.89	2.48	0.44	0.52	170	6.62	9.46	815
Sale and/or Maturity of Investments	-	-	-	-	-	-	0.00	3.88	0.00
Net Cash From Financing Activities	-267	-356	-295	-163	346	116	-499	-85	-1,572
Net Cash From Continuing Financing Activities	-267	-356	-295	-163	346	116	-499	-85	-1,572
Repayment of Debt	-370	-213	-113	-28	-78	-924	-155	-50	-1,087
Repurchase of Preferred Equity	-	-	-	-	-	-721	-91	0.00	-80
Repurchase of Common Equity	-98	-65	-81	-51	-15	-56	-309	-12	-211
Payment of Dividends	-103	-106	-114	-125	-140	-197	-186	-208	-222
Issuance of Debt	-	29	13	35	577	2,010	242	181	25
Issuance of Common Equity	9.98	0.00	0.00	6.05	2.26	3.67	0.00	2.99	2.53
Effect of Exchange Rate Changes	-19	21	-12	-8.73	20	-6.29	-15	-2.06	0.19

This table details how cash moves in and out of STERIS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Change in Cash & Equivalents	0.26	5.14	-18	11	-7.40	-26	-17	17	108	40	105
Net Cash From Operating Activities	281	146	291	255	304	251	333	261	420	288	298
Net Cash From Continuing Operating Activities	281	146	291	255	304	255	333	250	420	287	298
Net Income / (Loss) Continuing Operations	124	116	141	-1.00	146	151	173	146	178	192	194
Consolidated Net Income / (Loss)	124	116	141	-1.00	146	151	173	146	178	192	194
Depreciation Expense	138	152	141	134	113	115	126	122	119	122	122
Non-Cash Adjustments To Reconcile Net Income	14	18	20	249	0.20	35	7.90	16	26	20	18
Changes in Operating Assets and Liabilities, net	5.75	-140	-15	-128	45	-47	26	-34	96	-47	-36
Net Cash From Investing Activities	-67	-606	-119	-96	688	-105	-124	-70	-109	-88	-99
Net Cash From Continuing Investing Activities	-67	-606	-119	-96	688	-105	-124	-70	-109	-88	-98
Purchase of Property, Plant & Equipment	-67	-83	-119	-91	-108	-102	-89	-71	-94	-87	-99
Acquisitions	0.00	-540	-	-6.50	-14	-3.81	-36	-0.48	-15	-	-5.10
Purchase of Investments	-	-	-	-	-	-	-	-	-	-	-5.00
Net Cash From Financing Activities	-214	470	-198	-144	-999	-181	-214	-178	-213	-159	-98
Net Cash From Continuing Financing Activities	-214	470	-198	-144	-999	-181	-214	-178	-213	-159	-98
Repayment of Debt	-14	-14	248	173	-886	-92	282	-386	-156	47	-52
Repurchase of Common Equity	-8.72	-0.49	-2.23	-0.33	-64	-46	-100	-0.26	-11	-101	-50
Payment of Dividends	-47	-51	-59	-51	-52	-56	-58	-57	-56	-62	-63
Issuance of Debt	-145	536	-387	-266	-	14	-338	344	9.30	-44	67
Effect of Exchange Rate Changes	-0.64	-4.93	7.50	-	-	9.46	-12	3.61	9.60	-0.90	2.90

This table presents STERIS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Total Assets	5,200	5,073	5,441	6,574	11,424	10,822	11,064	10,147
Total Current Assets	990	1,054	1,224	1,212	1,879	2,011	2,869	2,001
Cash & Equivalents	202	221	320	221	348	208	207	172
Accounts Receivable	528	555	586	609	799	865	1,008	1,044
Inventories, net	206	208	264	315	575	604	675	581
Prepaid Expenses	54	60	54	67	157	176	174	204
Plant, Property, & Equipment, net	1,011	1,032	1,112	1,235	1,553	1,633	1,765	1,957
Total Noncurrent Assets	3,200	2,988	3,105	4,127	7,992	7,178	6,429	6,190
Goodwill	2,434	2,323	2,356	3,026	4,404	3,879	4,071	4,096
Intangible Assets	727	605	565	898	3,329	2,077	2,119	1,854
Other Noncurrent Operating Assets	39	60	183	203	259	244	239	239
Total Liabilities & Shareholders' Equity	5,200	5,073	5,441	6,574	11,424	10,822	11,064	10,147
Total Liabilities	1,983	1,887	2,023	2,683	4,879	4,735	4,748	3,531
Total Current Liabilities	398	465	504	578	922	862	931	1,022
Short-Term Debt	-	0.00	20	0.00	143	60	86	125
Accounts Payable	136	153	149	157	226	264	252	281
Accrued Expenses	168	188	192	221	307	298	320	368
Current Deferred & Payable Income Tax Liabilities	0.38	15	14	28	27	40	14	21
Current Employee Benefit Liabilities	94	109	128	150	184	118	165	193
Other Current Liabilities	-	-	-	23	36	30	31	34
Total Noncurrent Liabilities	1,585	1,422	1,519	2,105	3,957	3,873	3,817	2,509
Long-Term Debt	1,316	1,183	1,151	1,651	2,945	3,019	3,120	1,919
Capital Lease Obligations	-	0.00	114	130	155	140	146	125
Noncurrent Deferred & Payable Income Tax Liabilities	160	151	164	237	781	618	480	404
Other Noncurrent Operating Liabilities	109	88	90	88	76	76	72	62
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,217	3,186	3,418	3,891	6,545	6,087	6,315	6,616
Total Preferred & Common Equity	3,206	3,178	3,405	3,881	6,532	6,077	6,302	6,603
Total Common Equity	3,206	3,178	3,405	3,881	6,532	6,077	6,302	6,603
Common Stock	2,048	1,999	1,982	2,003	4,743	4,486	4,543	4,420
Retained Earnings	1,146	1,339	1,659	1,939	1,999	1,912	2,088	2,475
Accumulated Other Comprehensive Income / (Loss)	12	-160	-235	-61	-210	-321	-329	-292
Noncontrolling Interest	11	7.99	13	10	12	9.97	13	12

This table presents STERIS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	6/30/2025	9/30/2025	12/31/2025
Total Assets	10,822	10,784	11,281	11,435	11,064	10,109	10,242	10,008	10,405	10,411	10,591
Total Current Assets	2,011	2,031	2,174	2,219	2,869	1,940	1,938	1,898	2,058	2,106	2,286
Cash & Equivalents	208	209	214	196	207	198	172	155	280	319	424
Accounts Receivable	865	888	940	964	1,008	893	923	915	947	947	991
Inventories, net	604	769	821	856	675	699	689	650	641	659	674
Prepaid Expenses	176	166	199	204	174	151	153	178	190	181	198
Plant, Property, & Equipment, net	1,633	1,726	1,744	1,844	1,765	1,834	1,930	1,922	2,055	2,092	2,133
Total Noncurrent Assets	7,178	7,027	7,363	7,372	6,429	6,334	6,375	6,189	6,292	6,213	6,172
Goodwill	3,879	3,887	4,040	4,112	4,071	4,057	4,151	4,044	4,223	4,215	4,232
Intangible Assets	2,077	2,865	3,058	2,987	2,119	2,049	2,004	1,923	1,817	1,749	1,692
Other Noncurrent Operating Assets	244	275	265	273	239	228	220	222	252	249	249
Total Liabilities & Shareholders' Equity	10,822	10,784	11,281	11,435	11,064	10,109	10,242	10,008	10,405	10,411	10,591
Total Liabilities	4,735	4,606	5,091	5,007	4,748	3,738	3,632	3,580	3,435	3,388	3,424
Total Current Liabilities	862	887	873	914	931	834	805	891	927	889	922
Short-Term Debt	60	63	71	78	86	80	80	125	0.00	0.00	0.00
Accounts Payable	264	261	294	277	252	232	235	238	301	309	285
Accrued Expenses	298	333	307	318	320	287	307	335	371	360	405
Current Deferred & Payable Income Tax Liabilities	40	64	32	25	14	57	5.85	0.00	65	17	9.90
Current Employee Benefit Liabilities	118	132	136	179	165	149	147	161	155	168	188
Other Current Liabilities	30	34	34	37	31	30	31	32	35	35	34
Total Noncurrent Liabilities	3,873	3,719	4,218	4,093	3,817	2,904	2,826	2,689	2,509	2,499	2,501
Long-Term Debt	3,019	2,860	3,366	3,231	3,120	2,236	2,156	2,039	1,903	1,897	1,898
Capital Lease Obligations	140	165	162	163	146	139	133	124	130	126	121
Noncurrent Deferred & Payable Income Tax Liabilities	618	618	613	621	480	456	463	453	411	412	415
Other Noncurrent Operating Liabilities	76	77	77	78	72	72	74	73	64	64	67
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	6,087	6,178	6,189	6,428	6,315	6,370	6,610	6,429	6,970	7,023	7,168
Total Preferred & Common Equity	6,077	6,168	6,178	6,415	6,302	6,355	6,593	6,416	6,957	7,009	7,155
Total Common Equity	6,077	6,168	6,178	6,415	6,302	6,355	6,593	6,416	6,957	7,009	7,155
Common Stock	4,486	4,498	4,519	4,534	4,543	4,500	4,491	4,405	4,431	4,359	4,340
Retained Earnings	1,912	1,981	2,046	2,134	2,088	2,178	2,268	2,386	2,597	2,726	2,857
Accumulated Other Comprehensive Income / (Loss)	-321	-311	-387	-253	-329	-323	-166	-374	-71	-76	-43
Noncontrolling Interest	9.97	10	11	13	13	16	17	12	13	14	13

This table displays calculated financial ratios and metrics derived from STERIS's official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.28%	6.19%	8.94%	2.53%	35.91%	7.41%	13.28%	6.24%
EBITDA Growth	0.00%	39.93%	9.59%	15.05%	5.12%	39.03%	24.63%	5.68%	-4.13%
EBIT Growth	0.00%	76.99%	2.08%	30.19%	2.91%	-17.74%	72.74%	7.48%	4.17%
NOPAT Growth	0.00%	142.39%	3.32%	29.39%	-4.25%	-11.88%	74.56%	1.76%	1.13%
Net Income Growth	0.00%	163.60%	4.50%	33.84%	-2.69%	-38.80%	-56.43%	259.20%	62.09%
EPS Growth	0.00%	164.84%	4.72%	34.08%	-2.73%	-46.44%	-56.85%	256.07%	62.73%
Operating Cash Flow Growth	0.00%	7.91%	17.89%	9.46%	16.78%	-0.70%	10.53%	28.58%	17.96%
Free Cash Flow Firm Growth	0.00%	0.00%	113.30%	-63.41%	-432.34%	-458.72%	156.74%	-101.33%	2,922.82%
Invested Capital Growth	0.00%	0.00%	-4.46%	5.90%	24.37%	73.17%	-14.89%	8.53%	-1.23%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	1.84%	1.65%	-0.58%	-5.17%	-4.97%	1.13%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	1.99%	-0.48%	16.75%	72.53%	1.64%	-1.77%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	2.61%	-2.09%	-0.09%	493.45%	3.14%	-1.37%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	3.97%	-8.50%	5.78%	656.23%	-3.12%	-2.35%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	3.75%	-8.43%	-12.50%	463.64%	-33.09%	31.36%
EPS Q/Q Growth	0.00%	0.00%	0.00%	3.70%	-8.13%	-14.19%	635.00%	-33.28%	31.91%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	3.56%	-1.62%	-2.30%	6.18%	4.18%	0.52%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-12.85%	6.91%	239.73%	-46.17%	-57.68%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-1.66%	-0.72%	-2.96%	-10.80%	-10.15%	0.60%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	39.28%	41.71%	42.23%	43.55%	43.22%	44.59%	43.66%	43.17%	44.01%
EBITDA Margin	15.97%	22.29%	23.00%	24.29%	24.91%	25.48%	29.56%	27.58%	24.89%
Operating Margin	8.66%	15.26%	14.77%	17.72%	17.65%	11.31%	17.44%	16.27%	15.87%
EBIT Margin	8.77%	15.48%	14.88%	17.78%	17.85%	10.80%	17.38%	16.49%	16.16%
Profit (Net Income) Margin	4.23%	11.13%	10.95%	13.46%	12.77%	5.75%	2.33%	7.40%	11.28%
Tax Burden Percent	59.92%	82.15%	82.58%	81.78%	76.69%	66.21%	15.55%	54.08%	77.38%
Interest Burden Percent	80.57%	87.52%	89.13%	92.53%	93.30%	80.39%	86.30%	82.96%	90.23%
Effective Tax Rate	40.08%	17.85%	17.42%	18.22%	23.32%	22.45%	18.24%	21.28%	23.19%
Return on Invested Capital (ROIC)	0.00%	15.17%	8.01%	10.31%	8.55%	4.98%	7.40%	7.86%	7.68%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	8.55%	4.66%	7.04%	6.68%	-0.76%	-14.94%	-4.93%	5.43%
Return on Net Nonoperating Assets (RNNOA)	0.00%	2.96%	1.50%	2.04%	2.31%	-0.32%	-5.73%	-1.73%	1.85%
Return on Equity (ROE)	0.00%	18.13%	9.52%	12.35%	10.86%	4.65%	1.68%	6.13%	9.53%
Cash Return on Invested Capital (CROIC)	0.00%	-184.83%	12.57%	4.57%	-13.17%	-48.59%	23.50%	-0.33%	8.92%
Operating Return on Assets (OROA)	0.00%	7.80%	8.06%	10.25%	9.23%	5.07%	7.09%	7.74%	8.32%
Return on Assets (ROA)	0.00%	5.61%	5.93%	7.76%	6.61%	2.70%	0.95%	3.47%	5.81%
Return on Common Equity (ROCE)	0.00%	18.06%	9.49%	12.31%	10.82%	4.64%	1.67%	6.12%	9.51%
Return on Equity Simple (ROE_SIMPLE)	0.00%	9.10%	9.59%	11.98%	10.23%	3.72%	1.74%	6.03%	9.33%
Net Operating Profit after Tax (NOPAT)	136	329	339	439	421	371	647	658	666
NOPAT Margin	5.19%	12.54%	12.20%	14.49%	13.53%	8.77%	14.26%	12.81%	12.19%
Net Nonoperating Expense Percent (NNEP)	0.00%	6.62%	3.35%	3.27%	1.87%	5.73%	22.35%	12.79%	2.25%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	7.58%
Cost of Revenue to Revenue	60.72%	58.29%	57.77%	56.45%	56.78%	55.41%	56.34%	56.83%	55.99%
SG&A Expenses to Revenue	26.10%	24.12%	24.08%	23.65%	23.53%	31.22%	24.04%	24.37%	24.44%
R&D to Revenue	2.27%	2.32%	2.27%	2.16%	2.13%	2.05%	2.17%	2.02%	1.97%
Operating Expenses to Revenue	30.62%	26.45%	27.46%	25.83%	25.57%	33.27%	26.22%	26.89%	28.14%
Earnings before Interest and Taxes (EBIT)	229	406	414	539	555	456	788	847	882
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	417	584	640	736	774	1,076	1,341	1,417	1,359
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	3.37	4.09	3.64	3.10	3.53	3.37
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	23.72	0.00	0.00	155.13	198.05	34.08
Price to Revenue (P/Rev)	0.00	0.00	0.00	3.79	5.10	5.62	4.15	4.32	4.08
Price to Earnings (P/E)	0.00	0.00	0.00	28.15	39.92	97.39	175.79	58.73	36.23
Dividend Yield	1.68%	1.38%	1.08%	1.07%	0.84%	0.71%	0.97%	0.90%	0.98%
Earnings Yield	0.00%	0.00%	0.00%	3.55%	2.51%	1.03%	0.57%	1.70%	2.76%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	2.84	3.20	2.82	2.72	2.91	2.82
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	4.11	5.61	6.31	4.81	4.94	4.45
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	16.92	22.52	24.77	16.28	17.90	17.87
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	23.10	31.43	58.42	27.70	29.95	27.51
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	28.36	41.46	71.94	33.76	38.55	36.47
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	21.09	25.28	38.93	28.85	26.07	21.15
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	63.92	0.00	0.00	10.64	0.00	31.42
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.41	0.37	0.38	0.46	0.50	0.53	0.53	0.33
Long-Term Debt to Equity	0.00	0.41	0.37	0.37	0.46	0.47	0.52	0.52	0.31
Financial Leverage	0.00	0.35	0.32	0.29	0.35	0.43	0.38	0.35	0.34
Leverage Ratio	0.00	1.62	1.60	1.59	1.64	1.72	1.76	1.76	1.64
Compound Leverage Factor	0.00	1.41	1.43	1.47	1.53	1.39	1.52	1.46	1.48
Debt to Total Capital	0.00%	29.03%	27.08%	27.31%	31.39%	33.14%	34.58%	34.67%	24.68%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.42%	0.00%	1.46%	0.64%	0.89%	1.42%
Long-Term Debt to Total Capital	0.00%	29.03%	27.08%	26.89%	31.39%	31.68%	33.94%	33.78%	23.26%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.25%	0.18%	0.27%	0.18%	0.13%	0.11%	0.14%	0.14%
Common Equity to Total Capital	0.00%	70.72%	72.74%	72.41%	68.43%	66.74%	65.31%	65.19%	75.17%
Debt to EBITDA	0.00	2.25	1.85	1.74	2.30	3.01	2.40	2.37	1.60
Net Debt to EBITDA	0.00	1.91	1.50	1.31	2.02	2.69	2.24	2.22	1.47
Long-Term Debt to EBITDA	0.00	2.25	1.85	1.72	2.30	2.88	2.35	2.30	1.50
Debt to NOPAT	0.00	4.01	3.49	2.92	4.23	8.75	4.98	5.09	3.26
Net Debt to NOPAT	0.00	3.39	2.84	2.20	3.71	7.81	4.65	4.78	3.00
Long-Term Debt to NOPAT	0.00	4.01	3.49	2.88	4.23	8.37	4.88	4.96	3.07
Altman Z-Score	0.00	0.00	0.00	4.87	4.83	3.77	3.42	4.00	5.07
Noncontrolling Interest Sharing Ratio	0.00%	0.35%	0.30%	0.32%	0.32%	0.22%	0.18%	0.19%	0.20%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	2.48	2.27	2.43	2.10	2.04	2.33	3.08	1.96
Quick Ratio	0.00	1.83	1.67	1.80	1.44	1.24	1.25	1.31	1.19
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-4,003	532	195	-648	-3,618	2,053	-27	773
Operating Cash Flow to CapEx	252.35%	280.13%	292.97%	280.74%	288.92%	239.59%	217.90%	275.76%	318.12%
Free Cash Flow to Firm to Interest Expense	0.00	-79.07	11.83	4.84	-17.42	-40.43	19.02	-0.19	8.96
Operating Cash Flow to Interest Expense	9.53	9.04	11.99	14.66	18.55	7.65	7.01	6.74	13.31
Operating Cash Flow Less CapEx to Interest Expense	5.75	5.81	7.89	9.44	12.13	4.46	3.79	4.30	9.13
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.50	0.54	0.58	0.52	0.47	0.41	0.47	0.51
Accounts Receivable Turnover	0.00	4.96	5.14	5.31	5.20	6.00	5.45	5.49	5.32
Inventory Turnover	0.00	7.42	7.76	7.25	6.10	5.26	4.33	4.57	4.87
Fixed Asset Turnover	0.00	2.59	2.72	2.83	2.65	3.03	2.85	3.02	2.93
Accounts Payable Turnover	0.00	11.24	11.13	11.32	11.52	12.23	10.43	11.32	11.48
Days Sales Outstanding (DSO)	0.00	73.57	71.06	68.74	70.23	60.86	66.95	66.53	68.60
Days Inventory Outstanding (DIO)	0.00	49.17	47.01	50.33	59.85	69.41	84.23	79.92	74.98
Days Payable Outstanding (DPO)	0.00	32.47	32.79	32.24	31.68	29.84	34.99	32.24	31.79
Cash Conversion Cycle (CCC)	0.00	90.26	85.27	86.83	98.40	100.43	116.19	114.21	111.79
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	4,332	4,139	4,383	5,451	9,440	8,034	8,719	8,612
Invested Capital Turnover	0.00	1.21	0.66	0.71	0.63	0.57	0.52	0.61	0.63
Increase / (Decrease) in Invested Capital	0.00	4,332	-193	244	1,068	3,989	-1,406	686	-107
Enterprise Value (EV)	0.00	0.00	0.00	12,454	17,433	26,659	21,834	25,373	24,278
Market Capitalization	0.00	0.00	0.00	11,476	15,863	23,751	18,814	22,215	22,269
Book Value per Share	$0.00	$0.00	$37.59	$40.15	$45.47	$65.24	$61.21	$63.78	$67.21
Tangible Book Value per Share	$0.00	$0.00	$2.96	$5.70	($0.51)	($11.99)	$1.22	$1.14	$6.65
Total Capital	0.00	4,533	4,369	4,703	5,672	9,788	9,305	9,667	8,784
Total Debt	0.00	1,316	1,183	1,284	1,780	3,243	3,218	3,352	2,168
Total Long-Term Debt	0.00	1,316	1,183	1,265	1,780	3,101	3,158	3,266	2,043
Net Debt	0.00	1,114	963	965	1,560	2,895	3,010	3,145	1,997
Capital Expenditures (CapEx)	168	163	184	210	239	286	347	353	361
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	390	368	421	413	751	1,001	1,817	932
Debt-free Net Working Capital (DFNWC)	0.00	591	589	740	634	1,100	1,210	2,024	1,104
Net Working Capital (NWC)	0.00	591	589	720	634	957	1,150	1,938	979
Net Nonoperating Expense (NNE)	25	37	35	31	24	128	541	278	50
Net Nonoperating Obligations (NNO)	0.00	1,114	953	965	1,560	2,895	1,947	2,404	1,997
Total Depreciation and Amortization (D&A)	188	178	226	197	219	620	553	570	476
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	14.87%	13.22%	13.88%	13.30%	17.79%	22.07%	35.36%	17.07%
Debt-free Net Working Capital to Revenue	0.00%	22.56%	21.15%	24.42%	20.40%	26.04%	26.67%	39.39%	20.21%
Net Working Capital to Revenue	0.00%	22.56%	21.15%	23.77%	20.40%	22.65%	25.34%	37.71%	17.92%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$3.59	$4.81	$4.66	$2.50	$1.07	$3.83	$6.24
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$3.56	$4.76	$4.63	$2.48	$1.07	$3.81	$6.20
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	84.54M	84.92M	170.74M	200.16M	197.30M	197.80M	98.37M
Normalized Net Operating Profit after Tax (NOPAT)	171	329	365	440	418	371	647	679	701
Normalized NOPAT Margin	6.53%	12.54%	13.12%	14.51%	13.46%	8.77%	14.27%	13.21%	12.84%
Pre Tax Income Margin	7.07%	13.55%	13.26%	16.46%	16.65%	8.69%	15.00%	13.68%	14.58%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.15	8.01	9.20	13.38	14.92	5.10	7.30	5.87	10.23
NOPAT to Interest Expense	3.04	6.49	7.54	10.90	11.31	4.14	5.99	4.56	7.72
EBIT Less CapEx to Interest Expense	1.37	4.78	5.11	8.16	8.50	1.90	4.08	3.42	6.05
NOPAT Less CapEx to Interest Expense	-0.73	3.26	3.45	5.68	4.89	0.95	2.77	2.11	3.53
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	93.20%	36.48%	37.44%	30.62%	35.38%	81.05%	175.56%	54.82%	36.08%
Augmented Payout Ratio	181.34%	58.94%	64.18%	43.19%	39.07%	104.02%	467.17%	57.92%	70.38%

This table displays calculated financial ratios and metrics derived from STERIS's official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.33%	3.14%	6.72%	15.87%	8.12%	7.33%	5.61%	4.31%	8.72%	9.89%	9.16%
EBITDA Growth	13.69%	302.27%	12.95%	-56.66%	-5.55%	-4.41%	1.24%	-6.77%	15.36%	18.13%	5.67%
EBIT Growth	26.34%	162.81%	20.99%	-66.40%	3.27%	11.29%	8.44%	-5.41%	20.53%	24.88%	10.13%
NOPAT Growth	19.11%	169.22%	20.95%	-70.49%	-4.32%	14.93%	4.73%	-9.23%	27.48%	18.45%	10.77%
Net Income Growth	11.77%	136.91%	14.29%	-100.54%	17.57%	29.93%	22.95%	14,678.34%	22.34%	27.31%	12.12%
EPS Growth	13.64%	136.83%	14.52%	-101.06%	16.80%	30.17%	23.24%	7,500.00%	22.60%	28.48%	12.00%
Operating Cash Flow Growth	21.31%	40.71%	41.67%	18.08%	8.04%	71.62%	14.28%	2.34%	38.29%	14.75%	-10.40%
Free Cash Flow Firm Growth	-34.81%	-184.60%	-160.03%	-123.65%	66.78%	233.46%	355.44%	152.69%	-84.08%	-69.81%	-99.75%
Invested Capital Growth	-2.08%	9.76%	7.75%	8.53%	-4.76%	-8.01%	-11.79%	-1.23%	1.12%	-0.92%	2.37%
Revenue Q/Q Growth	22.85%	4.63%	4.81%	-20.03%	14.63%	3.86%	3.13%	8.02%	-6.04%	4.97%	2.46%
EBITDA Q/Q Growth	-62.16%	2.37%	7.00%	6.19%	-17.55%	3.60%	13.32%	-9.89%	9.03%	6.13%	1.31%
EBIT Q/Q Growth	-73.40%	-3.19%	18.55%	15.27%	-18.25%	4.34%	15.51%	-13.48%	15.56%	8.15%	1.79%
NOPAT Q/Q Growth	-76.69%	-4.11%	19.55%	15.34%	-24.41%	15.17%	8.95%	-13.46%	17.37%	7.06%	1.85%
Net Income Q/Q Growth	-33.79%	-6.01%	21.14%	-100.71%	14,625.05%	3.87%	14.63%	-15.70%	21.86%	8.15%	0.94%
EPS Q/Q Growth	-33.51%	-7.20%	22.41%	-101.41%	7,400.00%	3.42%	15.89%	-15.43%	20.95%	8.38%	1.03%
Operating Cash Flow Q/Q Growth	30.27%	-48.03%	99.35%	-12.51%	19.21%	-17.45%	32.75%	-21.65%	61.05%	-31.48%	3.61%
Free Cash Flow Firm Q/Q Growth	-83.23%	-302.36%	25.90%	7.31%	218.29%	61.93%	41.82%	-79.86%	-65.58%	207.08%	-98.83%
Invested Capital Q/Q Growth	12.75%	5.70%	1.36%	-10.15%	-1.06%	2.09%	-2.80%	0.60%	1.29%	0.03%	0.42%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.70%	44.11%	43.15%	40.19%	44.74%	43.55%	44.53%	43.31%	45.14%	44.23%	43.81%
EBITDA Margin	28.48%	27.87%	28.45%	34.59%	24.88%	24.82%	27.27%	22.75%	26.40%	26.69%	26.39%
Operating Margin	16.71%	15.47%	17.45%	21.97%	14.50%	16.53%	17.90%	14.60%	17.68%	18.20%	18.26%
EBIT Margin	16.83%	15.57%	17.61%	22.54%	16.07%	16.15%	18.08%	14.48%	17.81%	18.35%	18.23%
Profit (Net Income) Margin	10.46%	9.40%	10.86%	-0.09%	11.37%	11.38%	12.64%	9.87%	12.80%	13.18%	12.99%
Tax Burden Percent	74.22%	74.65%	74.34%	-0.47%	83.04%	77.57%	75.75%	74.03%	76.76%	76.06%	75.37%
Interest Burden Percent	83.75%	80.84%	82.96%	85.65%	85.22%	90.83%	92.30%	92.02%	93.58%	94.44%	94.50%
Effective Tax Rate	21.71%	22.49%	21.62%	20.08%	20.15%	22.32%	24.21%	25.57%	23.24%	23.94%	24.63%
Return on Invested Capital (ROIC)	6.52%	6.03%	6.85%	10.77%	6.85%	7.44%	8.02%	6.85%	8.72%	9.00%	9.26%
ROIC Less NNEP Spread (ROIC-NNEP)	5.43%	5.01%	5.67%	1.72%	6.75%	6.74%	7.55%	6.17%	8.18%	8.51%	8.64%
Return on Net Nonoperating Assets (RNNOA)	2.46%	2.63%	2.84%	0.60%	2.76%	2.94%	3.18%	2.10%	2.46%	2.44%	2.37%
Return on Equity (ROE)	8.99%	8.66%	9.68%	11.37%	9.62%	10.38%	11.19%	8.95%	11.17%	11.44%	11.63%
Cash Return on Invested Capital (CROIC)	9.44%	2.93%	4.83%	-0.33%	12.24%	15.68%	19.99%	8.92%	7.03%	9.34%	6.41%
Operating Return on Assets (OROA)	6.99%	6.58%	7.42%	10.58%	8.05%	7.99%	9.10%	7.46%	9.68%	10.13%	10.32%
Return on Assets (ROA)	4.34%	3.97%	4.57%	-0.04%	5.70%	5.63%	6.37%	5.08%	6.95%	7.28%	7.35%
Return on Common Equity (ROCE)	8.97%	8.64%	9.66%	11.35%	9.60%	10.36%	11.17%	8.93%	11.15%	11.41%	11.61%
Return on Equity Simple (ROE_SIMPLE)	1.93%	8.91%	8.85%	0.00%	6.32%	6.62%	7.31%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	155	148	177	196	148	171	186	161	189	202	206
NOPAT Margin	13.08%	11.99%	13.68%	17.56%	11.58%	12.84%	13.56%	10.87%	13.57%	13.84%	13.76%
Net Nonoperating Expense Percent (NNEP)	1.09%	1.02%	1.17%	9.06%	0.10%	0.70%	0.47%	0.67%	0.54%	0.50%	0.62%
Return On Investment Capital (ROIC_SIMPLE)	-	-	1.79%	-	-	-	2.13%	1.83%	2.10%	2.23%	2.24%
Cost of Revenue to Revenue	55.30%	55.89%	56.85%	59.81%	55.26%	56.45%	55.47%	56.69%	54.86%	55.77%	56.19%
SG&A Expenses to Revenue	25.90%	26.52%	23.76%	13.63%	26.23%	24.78%	24.48%	22.55%	25.43%	23.95%	23.55%
R&D to Revenue	2.09%	2.12%	1.95%	2.26%	2.00%	2.03%	2.00%	1.87%	1.90%	1.93%	1.97%
Operating Expenses to Revenue	27.99%	28.64%	25.70%	18.22%	30.24%	27.02%	26.63%	28.71%	27.46%	26.03%	25.54%
Earnings before Interest and Taxes (EBIT)	199	193	229	252	206	215	248	214	248	268	273
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	337	345	369	386	318	330	374	337	367	390	395
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.56	3.48	3.35	3.53	3.42	3.63	3.16	3.37	3.40	3.48	3.48
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	198.05	87.25	54.56	45.20	34.08	25.78	23.33	20.21
Price to Revenue (P/Rev)	4.82	4.67	4.59	4.32	4.15	4.49	3.76	4.08	4.24	4.27	4.27
Price to Earnings (P/E)	184.26	39.04	37.96	58.73	54.27	55.01	43.39	36.23	36.54	35.39	35.15
Dividend Yield	0.84%	0.89%	0.91%	0.90%	0.95%	0.88%	1.06%	0.98%	0.95%	0.95%	0.95%
Earnings Yield	0.54%	2.56%	2.63%	1.70%	1.84%	1.82%	2.30%	2.76%	2.74%	2.83%	2.85%
Enterprise Value to Invested Capital (EV/IC)	2.75	2.60	2.56	2.91	2.78	2.97	2.62	2.82	2.91	2.99	3.02
Enterprise Value to Revenue (EV/Rev)	5.45	5.40	5.30	4.94	4.58	4.91	4.16	4.45	4.56	4.57	4.55
Enterprise Value to EBITDA (EV/EBITDA)	18.00	13.09	12.77	17.90	17.21	18.96	16.22	17.87	18.04	17.78	17.80
Enterprise Value to EBIT (EV/EBIT)	29.98	18.70	18.12	29.95	28.10	29.85	25.07	27.51	27.47	26.67	26.41
Enterprise Value to NOPAT (EV/NOPAT)	37.03	22.21	21.57	38.55	36.80	38.79	32.91	36.47	35.96	35.36	34.95
Enterprise Value to Operating Cash Flow (EV/OCF)	30.85	29.30	26.55	26.07	24.08	23.75	19.64	21.15	20.09	20.05	20.91
Enterprise Value to Free Cash Flow (EV/FCFF)	28.79	92.68	54.87	0.00	22.15	18.14	12.29	31.42	41.66	31.86	47.71
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.50	0.58	0.54	0.53	0.39	0.36	0.36	0.33	0.29	0.29	0.28
Long-Term Debt to Equity	0.49	0.57	0.53	0.52	0.37	0.35	0.34	0.31	0.29	0.29	0.28
Financial Leverage	0.45	0.52	0.50	0.35	0.41	0.44	0.42	0.34	0.30	0.29	0.27
Leverage Ratio	1.74	1.81	1.78	1.76	1.66	1.68	1.67	1.64	1.54	1.51	1.52
Compound Leverage Factor	1.46	1.47	1.48	1.51	1.42	1.53	1.54	1.51	1.44	1.43	1.43
Debt to Total Capital	33.33%	36.77%	35.07%	34.67%	27.82%	26.38%	26.24%	24.68%	22.59%	22.37%	21.98%
Short-Term Debt to Total Capital	0.68%	0.72%	0.79%	0.89%	0.91%	0.89%	1.43%	1.42%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	32.64%	36.05%	34.28%	33.78%	26.91%	25.49%	24.81%	23.26%	22.59%	22.37%	21.98%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.11%	0.11%	0.13%	0.14%	0.18%	0.19%	0.14%	0.14%	0.14%	0.15%	0.15%
Common Equity to Total Capital	66.56%	63.12%	64.80%	65.19%	72.00%	73.43%	73.61%	75.17%	77.27%	77.48%	77.87%
Debt to EBITDA	2.24	1.89	1.79	2.37	1.76	1.72	1.65	1.60	1.44	1.38	1.36
Net Debt to EBITDA	2.08	1.78	1.69	2.22	1.62	1.59	1.54	1.47	1.25	1.16	1.07
Long-Term Debt to EBITDA	2.19	1.86	1.75	2.30	1.70	1.66	1.56	1.50	1.44	1.38	1.36
Debt to NOPAT	4.60	3.22	3.02	5.09	3.77	3.52	3.36	3.26	2.88	2.74	2.66
Net Debt to NOPAT	4.29	3.02	2.85	4.78	3.46	3.26	3.13	3.00	2.48	2.31	2.11
Long-Term Debt to NOPAT	4.50	3.15	2.95	4.96	3.64	3.40	3.17	3.07	2.88	2.74	2.66
Altman Z-Score	3.73	3.39	3.45	3.82	4.50	4.98	4.48	4.85	5.22	5.46	5.53
Noncontrolling Interest Sharing Ratio	0.17%	0.19%	0.18%	0.19%	0.21%	0.22%	0.20%	0.20%	0.22%	0.22%	0.19%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.29	2.49	2.43	3.08	2.33	2.41	2.13	1.96	2.22	2.37	2.48
Quick Ratio	1.24	1.32	1.27	1.31	1.31	1.36	1.20	1.19	1.32	1.42	1.53
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	347	-703	-521	-490	579	938	1,330	268	92	283	3.32
Operating Cash Flow to CapEx	422.14%	192.39%	244.90%	278.51%	281.03%	246.07%	373.02%	422.70%	449.20%	332.72%	302.13%
Free Cash Flow to Firm to Interest Expense	10.73	-19.02	-13.37	-13.56	19.06	47.68	69.65	15.65	5.80	19.00	0.22
Operating Cash Flow to Interest Expense	8.69	3.96	7.48	7.06	10.00	12.75	17.43	15.24	26.42	19.32	20.01
Operating Cash Flow Less CapEx to Interest Expense	6.63	1.90	4.42	4.52	6.44	7.57	12.76	11.63	20.53	13.51	13.39
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.42	0.42	0.42	0.47	0.50	0.49	0.50	0.51	0.54	0.55	0.57
Accounts Receivable Turnover	5.53	5.35	5.24	5.49	5.88	5.72	5.75	5.32	6.06	6.10	6.12
Inventory Turnover	3.70	3.54	3.40	4.57	4.05	4.01	4.06	4.87	4.65	4.72	4.92
Fixed Asset Turnover	2.77	2.77	2.66	3.02	2.94	2.90	2.87	2.93	2.87	2.84	2.87
Accounts Payable Turnover	10.50	9.85	10.16	11.32	12.08	11.47	11.86	11.48	11.69	11.68	12.45
Days Sales Outstanding (DSO)	66.05	68.24	69.64	66.53	62.07	63.87	63.53	68.60	60.27	59.87	59.68
Days Inventory Outstanding (DIO)	98.61	103.10	107.22	79.92	90.07	90.91	89.95	74.98	78.55	77.40	74.12
Days Payable Outstanding (DPO)	34.76	37.06	35.92	32.24	30.22	31.83	30.78	31.79	31.23	31.25	29.32
Cash Conversion Cycle (CCC)	129.90	134.29	140.94	114.21	121.92	122.95	122.70	111.79	107.59	106.02	104.48
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	9,058	9,575	9,705	8,719	8,627	8,808	8,561	8,612	8,724	8,727	8,763
Invested Capital Turnover	0.50	0.50	0.50	0.61	0.59	0.58	0.59	0.63	0.64	0.65	0.67
Increase / (Decrease) in Invested Capital	-192	851	698	686	-431	-767	-1,144	-107	97	-81	203
Enterprise Value (EV)	24,876	24,866	24,804	25,373	23,985	26,133	22,435	24,278	25,398	26,088	26,491
Market Capitalization	21,987	21,469	21,515	22,215	21,713	23,919	20,290	22,269	23,631	24,371	24,882
Book Value per Share	$62.53	$62.54	$64.93	$63.78	$64.25	$66.86	$65.00	$67.21	$70.72	$71.16	$72.90
Tangible Book Value per Share	($5.91)	($9.31)	($6.92)	$1.14	$2.52	$4.45	$4.55	$6.65	$9.32	$10.61	$12.54
Total Capital	9,267	9,788	9,900	9,667	8,825	8,980	8,716	8,784	9,003	9,046	9,187
Total Debt	3,088	3,599	3,472	3,352	2,455	2,369	2,287	2,168	2,034	2,023	2,019
Total Long-Term Debt	3,025	3,528	3,394	3,266	2,375	2,289	2,162	2,043	2,034	2,023	2,019
Net Debt	2,880	3,386	3,277	3,145	2,257	2,197	2,132	1,997	1,754	1,704	1,596
Capital Expenditures (CapEx)	67	76	119	91	108	102	89	62	94	87	99
Debt-free, Cash-free Net Working Capital (DFCFNWC)	999	1,158	1,188	1,817	988	1,040	977	932	852	898	940
Debt-free Net Working Capital (DFNWC)	1,208	1,372	1,384	2,024	1,186	1,212	1,132	1,104	1,131	1,217	1,364
Net Working Capital (NWC)	1,144	1,301	1,305	1,938	1,106	1,132	1,007	979	1,131	1,217	1,364
Net Nonoperating Expense (NNE)	31	32	37	197	2.61	19	13	15	11	9.66	12
Net Nonoperating Obligations (NNO)	2,880	3,386	3,277	2,404	2,257	2,197	2,132	1,997	1,754	1,704	1,596
Total Depreciation and Amortization (D&A)	138	152	141	135	113	115	126	122	119	122	122
Debt-free, Cash-free Net Working Capital to Revenue	21.90%	25.17%	25.37%	35.36%	18.87%	19.53%	18.09%	17.07%	15.28%	15.75%	16.13%
Debt-free Net Working Capital to Revenue	26.47%	29.82%	29.55%	39.39%	22.66%	22.77%	20.96%	20.21%	20.30%	21.35%	23.40%
Net Working Capital to Revenue	25.08%	28.27%	27.87%	37.71%	21.13%	21.26%	18.65%	17.92%	20.30%	21.35%	23.40%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.25	$1.17	$1.42	($0.01)	$1.47	$1.52	$1.76	$1.49	$1.80	$1.95	$1.96
Adjusted Weighted Average Basic Shares Outstanding	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M	98.15M	98.08M
Adjusted Diluted Earnings per Share	$1.25	$1.16	$1.42	($0.02)	$1.46	$1.51	$1.75	$1.48	$1.79	$1.94	$1.96
Adjusted Weighted Average Diluted Shares Outstanding	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M	98.15M	98.08M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	197.56M	197.60M	197.63M	197.80M	197.23M	98.71M	98.25M	98.37M	98.49M	98.15M	98.08M
Normalized Net Operating Profit after Tax (NOPAT)	155	148	178	217	169	173	188	172	190	204	206
Normalized NOPAT Margin	13.09%	11.99%	13.68%	19.42%	13.18%	13.00%	13.69%	11.64%	13.67%	13.96%	13.78%
Pre Tax Income Margin	14.09%	12.59%	14.61%	19.30%	13.70%	14.67%	16.69%	13.33%	16.67%	17.33%	17.23%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.15	5.22	5.87	6.97	6.77	10.91	12.98	12.53	15.58	17.99	18.31
NOPAT to Interest Expense	4.79	4.02	4.56	5.43	4.88	8.68	9.74	9.40	11.88	13.57	13.82
EBIT Less CapEx to Interest Expense	4.10	3.16	2.81	4.43	3.21	5.73	8.31	8.92	9.70	12.18	11.68
NOPAT Less CapEx to Interest Expense	2.73	1.96	1.50	2.89	1.32	3.49	5.06	5.80	6.00	7.76	7.20
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	159.18%	35.17%	36.03%	54.82%	53.10%	49.98%	46.31%	36.08%	35.02%	33.73%	33.51%
Augmented Payout Ratio	405.39%	80.20%	65.26%	57.92%	69.84%	75.90%	91.38%	70.38%	59.33%	64.44%	56.22%

Financials Breakdown Chart

Key Financial Trends

STERIS plc (NYSE: STE) has shown solid revenue growth and margin improvement across the last four years of quarterly results, supported by a strong balance sheet and ongoing cash generation. The latest data for Q3 2026 highlights a continued lift in revenue, better gross margins, and meaningful operating cash flow, along with a robust equity base. Here are the top trends retail investors should note.

Revenue growth: Q3 2026 Operating Revenue was about $1,496,200,000, up from roughly $1,329,000,000 in Q3 2025 and about $1,480,531,000 in Q4 2024, indicating ongoing top-line expansion.
Gross margin improvement: Q3 2026 gross profit was $655,500,000 on $1,496,200,000 in revenue (about 44% gross margin), higher than roughly 39% in Q3 2025, signaling improved product mix or pricing leverage.
Net income trend: Consolidated net income/earnings attributable to common shareholders rose in Q3 2026 to about $192.9 million (net income to common shareholders), versus prior-year levels in the low-mid hundreds of millions, reflecting stronger profitability.
Earnings per share: Diluted earnings per share reached about $1.96 in Q3 2026, reflecting continued earnings growth per share against prior quarters.
Solid balance sheet: Total assets around $10.59B and total equity around $7.16B in Q3 2026, with a healthy equity base to support growth and capital deployment. The current ratio is favorable (roughly 2.5x), indicating good short‑term liquidity.
Cash from operations: Net cash from continuing operating activities in Q3 2026 was about $298.2 million, highlighting strong cash generation from core operations.
Free cash flow potential: With quarterly cash from operating activities around $298.2 million and capital expenditures (PPE) around $98.7 million in Q3 2026, estimated free cash flow runs near $200 million for the quarter, supporting debt reduction, dividends, and potential buybacks.
Investing activity: Cash used for investing remains meaningful due to capex and acquisitions (PPE and acquisitions), leading to a negative net cash from investing activities in several quarters, though typical for asset‑heavy health facilities support operations.
Financing activity: Net cash used in financing activities has been negative in several quarters (debt repayments, dividends, and occasional equity actions), reflecting ongoing capital allocation decisions that affect quarterly cash balance but may support long-term leverage and shareholder value.
Cash balance volatility: While Q3 2026 shows solid cash generation, quarterly net changes in cash and equivalents can be volatile due to timing of financing, investing, and working capital movements, indicating a need for continued monitoring of liquidity if operating cash flow slows.

05/14/26 07:17 AM ETAI Generated. May Contain Errors.

STERIS Financials - Frequently Asked Questions

According to the most recent income statement we have on file, STERIS's fiscal year ends in March. Their fiscal year 2025 ended on March 31, 2025.

STERIS's net income appears to be on an upward trend, with a most recent value of $616.07 million in 2025, rising from $110.63 million in 2017. The previous period was $380.08 million in 2024. Find out what analysts predict for STERIS in the coming months.

STERIS's total operating income in 2025 was $866.64 million, based on the following breakdown:

Total Gross Profit: $2.40 billion
Total Operating Expenses: $1.54 billion

Over the last 8 years, STERIS's total revenue changed from $2.61 billion in 2017 to $5.46 billion in 2025, a change of 109.0%.

STERIS's total liabilities were at $3.53 billion at the end of 2025, a 25.6% decrease from 2024, and a 78.1% increase since 2018.

In the past 7 years, STERIS's cash and equivalents has ranged from $171.70 million in 2025 to $348.32 million in 2022, and is currently $171.70 million as of their latest financial filing in 2025.

Over the last 8 years, STERIS's book value per share changed from 0.00 in 2017 to 67.21 in 2025, a change of 6,721.0%.

Related Companies

Financial statements for NYSE:STE last updated on 2/11/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STERIS (STE) Financials

Financials Breakdown Chart

Key Financial Trends

STERIS Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

STERIS (STE) Financials

Annual Income Statements for STERIS

Quarterly Income Statements for STERIS

Annual Cash Flow Statements for STERIS

Quarterly Cash Flow Statements for STERIS

Annual Balance Sheets for STERIS

Quarterly Balance Sheets for STERIS

Annual Metrics And Ratios for STERIS

Quarterly Metrics And Ratios for STERIS

Financials Breakdown Chart

Key Financial Trends

STERIS Financials - Frequently Asked Questions

When does STERIS's financial year end?

How has STERIS's net income changed over the last 8 years?

What is STERIS's operating income?

How has STERIS's revenue changed over the last 8 years?

How much debt does STERIS have?

How much cash does STERIS have?

How has STERIS's book value per share changed over the last 8 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools